Staging System Developed for Revision Rhinoplasty

This article originally appeared here.
Share this content:
Staging System Developed for Revision Rhinoplasty
Staging System Developed for Revision Rhinoplasty

FRIDAY, May 6, 2016 (HealthDay News) -- A PGS staging system, comprising three major components, has been developed for prognosis in revision rhinoplasty, according to a report published online May 5 in JAMA Facial Plastic Surgery.

Regina Rodman, M.D., and Russell Kridel, M.D., from the University of Texas Health Science Center at Houston, present components that could be used to classify patients presenting for revision rhinoplasty.

The authors describe three major components that determine the overall difficulty of revision rhinoplasty surgery, called the PGS system. P represents "problem," which describes the patients' specific anatomic anomaly. G represents "graft" and is based on the number of grafts required. S represents the number of previous "surgical" procedures. An additional component, E, represents patient "expectations," and can be added after the stage of a patient's condition has been ascertained using the PGS classification system.

"This preoperative staging system may help the patient understand the complexity of the repair required and help manage expectations," the authors write. "The PGS system will facilitate exchange of information between surgeons who perform revision rhinoplasty. A standardized evaluation system will allow meaningful comparisons of surgical techniques and evaluations of outcomes of rhinoplasty procedures."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Alzheimer's Mortality Up 55 Percent From 1999 to 2014

CDC: Alzheimer's Mortality Up 55 Percent From 1999 ...

More patients also dying at home, with the caregiving burden often falling on loved ones

Targeting ANGPTL3 Can Significantly Lower Cholesterol

Targeting <i>ANGPTL3</i> Can Significantly Lower Cholesterol

Two trials show promise for non-statin approach to cardiovascular disease prevention

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Infections, clotting disorders, chronic hypertension all found to increase risk

is free, fast, and customized just for you!

Already a member?

Sign In Now »